THE ROHATYN GROUP COMPLETES INVESTMENT IN EUROPEAN CONTRACT RESEARCH ORGANIZATION, OPTIMAPHARM
New York, NY, May 12, 2020 – The Rohatyn Group (“TRG”), an emerging markets focused asset management firm, today announced that it has completed an investment in Optimapharm d.d. (“Optimapharm” or the “Company”), to establish a partnership with the company’s founders Gordana Gregurić Čičak and…
The Rohatyn Group Completes Its Investment in Amethyst Radiotherapy, A Leading Operator of Oncology Radiotherapy Clinics Across Europe
New York, NY, November 5, 2019 – The Rohatyn Group (“TRG”), an emerging markets focused asset management firm, today announced an investment in Amethyst Radiotherapy (“Amethyst” or the “Company”), obtaining co-control of the Company alongside the two co-founders. Amethyst is one of the largest operators of…
THE ROHATYN GROUP ACQUIRES ROMANIAN PET SUPPLIES COMPANY ANIMAX AND SLOVENIAN PET SUPPLIES COMPANY MR. PET
New York, NY, October 9, 2018 – The Rohatyn Group (“TRG”), an emerging markets asset management firm, today announced the successful completion of its acquisitions of Pet Product SRL (“Pet Product” or “Animax”), one of the leading pet supplies companies in Romania, and MIMAJA d.o.o….
Colin Clark Discusses Investment Opportunity and Market Conditions in Eastern Europe with Baker & McKenzie PE Insights
Eastern Europe: Family Values Colin Clark, Managing Director and Head of The Rohatyn Group’s CEEMEA region, sees lots of investment opportunity in Eastern Europe, particularly through partnerships with family-owned businesses. He discusses the region’s market conditions and why TRG recently disposed of major investments in…